Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase "EASY"

Terminated

Phase N/A Results N/A

Update History

6 Dec '17
The gender criteria for eligibility was updated to "All."
A location was updated in Creteil.
New
The overall status was removed for Hopital Henri Mondor.
A location was updated in Paris.
New
The overall status was removed for Fondation Ophtalmologique Adolphe de Rothschild.
A location was updated in Suresnes.
New
The overall status was removed for Hopital Foch.
20 May '16
Trial acronym was updated.
New
EASY
29 Oct '15
The Summary of Purpose was updated.
New
This trial aims at comparing two strategies currently used to address acute ischemic stroke of the middle cerebral artery : medical treatment without endovascular treatment on the one hand, and medical treatment plus endovascular treatment on the other hand. The efficiency of the strategies will be assessed in terms of early neurological clinical recovery. The study will focus on three particular situations : (1) tandem internal carotid and middle cerebral artery occlusion, (2) situations where patient cannot benefit from fibrinolysis because of high risk of haemorrhage, (3) situations where fibrinolysis is not recommended because of a delay superior to 4.5 hours. The hypothesis to be tested is that medical approach plus endovascular treatment is superior to medical treatment alone
Old
This trial aims at comparing two strategies currently used to address acute ischemic stroke of the middle cerebral artery : medical treatment without endovascular treatment on the one hand, and medical treatment plus endovascular treatment on the other hand. The efficiency of the strategies will be assessed in terms of early neurological clinical recovery. The study will focus on three particular situations : (1) tandem internal carotid and middle cerebral artery occlusion, (2) situations where patient cannot benefit from fibrinolysis because of high risk of haemorrhage, (3) situations where fibrinolysis is not recommended because of a delay superior to 4.5 hours. The hypothesis to be tested is that medical approach plus endovascular treatment is superior to medical treatment alone
5 Mar '15
A location was updated in Paris.
New
The overall status was removed for Fondation Ophtalmologique Adolphe de Rothschild.